Healthcare provider profile · identity verified

Peter A Badroos, MD, MPH

Family Practice · COTTAGE GROVE, MN · NPI 1730140351

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	431	124
Losartan Potassium	Losartan Potassium	377	122
Rosuvastatin Calcium	Rosuvastatin Calcium	356	112
Metoprolol Succinate	Metoprolol Succinate	325	87
Amlodipine Besylate	Amlodipine Besylate	315	100
Omeprazole	Omeprazole	280	73
Lisinopril	Lisinopril	265	75
Levothyroxine Sodium	Levothyroxine Sodium	246	62
Metformin Hcl	Metformin Hcl	229	64
Simvastatin	Simvastatin	228	54
Tamsulosin Hcl	Tamsulosin Hcl	224	71
Escitalopram Oxalate	Escitalopram Oxalate	204	62
Albuterol Sulfate Hfa	Albuterol Sulfate	189	80
Furosemide	Furosemide	174	58
Gabapentin	Gabapentin	173	55
Pantoprazole Sodium	Pantoprazole Sodium	173	65
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	138	34
Eliquis	Apixaban	121	26
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	120	120
Prednisone	Prednisone	112	69
Metoprolol Tartrate	Metoprolol Tartrate	109	29
Azithromycin	Azithromycin	108	76
Fluticasone Propionate	Fluticasone Propionate	107	45
Metformin Hcl Er	Metformin Hcl	105	32
Allopurinol	Allopurinol	102	29
Clopidogrel	Clopidogrel Bisulfate	101	32
Sertraline Hcl	Sertraline Hcl	99	26
Finasteride	Finasteride	88	28
Jardiance	Empagliflozin	86	27
Trazodone Hcl	Trazodone Hcl	86	33
Pravastatin Sodium	Pravastatin Sodium	85	21
Glipizide Er	Glipizide	82	27
Hydrochlorothiazide	Hydrochlorothiazide	81	24
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	76	12
Meloxicam	Meloxicam	76	28
Farxiga	Dapagliflozin Propanediol	74	21
Donepezil Hcl	Donepezil Hcl	72	19
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	72	22
Tizanidine Hcl	Tizanidine Hcl	72	17
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	71	29
Naproxen	Naproxen	71	31
Fenofibrate	Fenofibrate	68	11
Zolpidem Tartrate	Zolpidem Tartrate	67	14
Tramadol Hcl	Tramadol Hcl	63	21
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	62	54
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	62	21
Meclizine Hcl	Meclizine Hcl	60	16
Eszopiclone	Eszopiclone	59	12
Potassium Chloride	Potassium Chloride	59	21
Ciprofloxacin Hcl	Ciprofloxacin Hcl	57	53
Fluconazole	Fluconazole	57	30
Warfarin Sodium	Warfarin Sodium	53	16
Ozempic	Semaglutide	52	12
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	51	16
Lorazepam	Lorazepam	51	13
Mirtazapine	Mirtazapine	51	21
Ibuprofen	Ibuprofen	50	22
Carvedilol	Carvedilol	49	16
Trulicity	Dulaglutide	49	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	47	20
Atenolol	Atenolol	45	12
Azelastine Hcl	Azelastine Hcl	45	24
Methocarbamol	Methocarbamol	44	15
Isosorbide Mononitrate Er	Isosorbide Mononitrate	43	suppressed
Clonidine Hcl	Clonidine Hcl	42	14
Nifedipine Er	Nifedipine	42	13
Xarelto	Rivaroxaban	41	14
Ezetimibe	Ezetimibe	40	12
Alendronate Sodium	Alendronate Sodium	37	suppressed
Cefdinir	Cefdinir	37	33
Fenofibrate	Fenofibrate Nanocrystallized	37	13
Nitroglycerin	Nitroglycerin	37	27
Ventolin Hfa	Albuterol Sulfate	37	13
Duloxetine Hcl	Duloxetine Hcl	35	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	35	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	35	20
Cephalexin	Cephalexin	34	29
Spironolactone	Spironolactone	34	12
Bupropion Xl	Bupropion Hcl	33	13
Methotrexate	Methotrexate Sodium	31	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	30	14
Cefuroxime	Cefuroxime Axetil	29	18
Citalopram Hbr	Citalopram Hydrobromide	29	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	29	12
Dicyclomine Hcl	Dicyclomine Hcl	28	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	28	14
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	28	suppressed
Pregabalin	Pregabalin	28	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	28	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	28	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	28	22
Olmesartan Medoxomil	Olmesartan Medoxomil	27	suppressed
Valacyclovir	Valacyclovir Hcl	27	14
Famotidine	Famotidine	26	suppressed
Montelukast Sodium	Montelukast Sodium	26	suppressed
Alprazolam	Alprazolam	25	suppressed
Chlorthalidone	Chlorthalidone	25	suppressed
Glipizide	Glipizide	23	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	23	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	22	suppressed
Bupropion Hcl Sr	Bupropion Hcl	21	suppressed
Lumigan	Bimatoprost	21	suppressed
Spiriva Respimat	Tiotropium Bromide	20	suppressed
Timolol Maleate	Timolol Maleate	20	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	19	19
Celecoxib	Celecoxib	19	suppressed
Clonazepam	Clonazepam	19	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	19	19
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	19	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	18	suppressed
Minocycline Hcl	Minocycline Hcl	18	suppressed
Oxycodone Hcl	Oxycodone Hcl	18	suppressed
Sucralfate	Sucralfate	18	suppressed
Diazepam	Diazepam	17	suppressed
Dulera	Mometasone/Formoterol	17	suppressed
Hydralazine Hcl	Hydralazine Hcl	17	suppressed
Ondansetron Odt	Ondansetron	17	12
Shingrix	Varicella-Zoster Ge/As01b/Pf	17	16
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	17	suppressed
Amoxicillin	Amoxicillin	16	suppressed
Bumetanide	Bumetanide	16	suppressed
Hydrocortisone	Hydrocortisone	16	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	15	15
Amitriptyline Hcl	Amitriptyline Hcl	15	suppressed
Lansoprazole	Lansoprazole	15	suppressed
Levetiracetam	Levetiracetam	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Risperidone	Risperidone	15	suppressed
Rizatriptan	Rizatriptan Benzoate	15	suppressed
Loperamide	Loperamide Hcl	14	suppressed
Mometasone Furoate	Mometasone Furoate	14	suppressed
Myrbetriq	Mirabegron	14	suppressed
Rybelsus	Semaglutide	14	suppressed
Clindamycin Phosphate	Clindamycin Phosphate	13	suppressed
Clobetasol Propionate	Clobetasol Propionate	13	suppressed
Diclofenac Sodium	Diclofenac Sodium	13	suppressed
Metolazone	Metolazone	13	suppressed
Neomycin-Polymyxin-Hc	Neomycin/Polymyxin B/Hydrocort	13	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	13	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Buspirone Hcl	Buspirone Hcl	12	suppressed
Latanoprost	Latanoprost	12	suppressed
Metronidazole	Metronidazole	12	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	12	suppressed
Prochlorperazine Maleate	Prochlorperazine Maleate	12	suppressed
Sulindac	Sulindac	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	11	suppressed
Pentoxifylline	Pentoxifylline	11	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error